Miconazole treatment for severe dermatophytoses.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D002176:Candida albicans / Q000302:isolation & purification; D002986:Clinical Trials as Topic; D003881:Dermatomycoses / Q000188:drug therapy* / Q000382:microbiology; D004341:Drug Evaluation; D004987:Ethers / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010919:Placebos; D012008:Recurrence; D012075:Remission, Spontaneous; D013997:Time Factors; D014005:Tinea / Q000188:drug therapy; D014008:Tinea Pedis / Q000188:drug therapy; D014249:Trichophyton / Q000302:isolation & purification
D000935:Antifungal Agents; D001593:Benzyl Compounds; D004987:Ethers; D007093:Imidazoles; D010919:Placebos